2022
The mirror mechanism in schizophrenia: A systematic review and qualitative meta-analysis
Valizadeh A, Mbwogge M, Yazdi A, Amlashi N, Haadi A, Shayestefar M, Moassefi M. The mirror mechanism in schizophrenia: A systematic review and qualitative meta-analysis. Frontiers In Psychiatry 2022, 13: 884828. PMID: 36213922, PMCID: PMC9532849, DOI: 10.3389/fpsyt.2022.884828.Peer-Reviewed Original ResearchMirror neuron activityCortical motor systemSchizophrenia patientsMirror neuron systemUnderlying pathophysiologyCertainty of evidenceCase-control studyNew rehabilitation methodWeb of ScienceObjective assessment toolEligible studiesHealthy controlsVisuomotor neuronsPatientsNeuron activityPositive symptomsSystematic reviewInvestigation of heterogeneityMicrostructural integrityVote counting methodNeuron systemPathophysiologySymptomsFunctional integrityRehabilitation methodsDisease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis
Valizadeh A, Fattahi M, Sadeghi M, Torbati M, Sahraian M, Azimi A. Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 2022, 28: 648-657. PMID: 35218155, PMCID: PMC8981477, DOI: 10.1111/cns.13815.Peer-Reviewed Original ResearchConceptsDisease-modifying therapiesCertainty of evidenceVolumes of T1Hypointense lesionsMultiple sclerosis patientsRisk of biasRoB 2 toolT1-hypointense lesionsRandom-effects modelEffects of FDANumber of lesionsAdult patientsSclerosis patientsMultiple sclerosisComparator groupPrognostic markerObjective markersSystematic reviewLesionsMean differenceMean volumePatientsRelevant studiesHypointenseTherapy
2021
Correlation between the clinical disability and T1 hypointense lesions’ volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta‐analysis
Valizadeh A, Moassefi M, Barati E, Sahraian M, Aghajani F, Fattahi M. Correlation between the clinical disability and T1 hypointense lesions’ volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 2021, 27: 1268-1280. PMID: 34605190, PMCID: PMC8504532, DOI: 10.1111/cns.13734.Peer-Reviewed Original ResearchConceptsMean volumeCerebral magnetic resonance imagingPrognosis Studies toolMultiple sclerosis patientsRisk of biasT1-hypointense lesionsRandom-effects modelMagnetic resonance imagingWeb of ScienceClinical disabilityAdult patientsCerebral MRIEDSS scoreSclerosis patientsMultiple sclerosisDisability levelHypointense lesionsSystematic reviewResonance imagingPatientsRelevant studiesStudy toolCorrelation coefficientT1EDSSA placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury.
Shimia M, Iranmehr A, Valizadeh A, Mirzaei F, Namvar M, Rafiei E, Rahimi A, Khadivi A, Aeinfar K. A placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury. Journal Of Neurosurgical Sciences 2021, 67: 598-604. PMID: 34114429, DOI: 10.23736/s0390-5616.21.05266-8.Peer-Reviewed Original ResearchConceptsGlasgow Outcome ScaleDisability Rating ScaleTraumatic brain injurySevere TBI patientsAmantadine hydrochlorideTBI patientsBrain injuryFunctional improvementClinical trialsSevere acute traumatic brain injuryAcute traumatic brain injuryMean Glasgow Outcome ScaleSevere traumatic brain injuryFunctional ability improvementEffect of amantadineDopaminergic neurotransmitter systemWeeks of trialAmantadine groupPharmacologic optionsDopamine agonistsOutcome ScaleNeurotransmitter systemsOutcome measurementsPatientsRating Scale